Noveris Health Sciences is trading 5.26% up at CA$0.10 in live trading data for September 10, 2026; no clear company-specific catalyst has been identified.
- The September 9 announcement reported that shareholders approved all resolutions at the September 4 annual and special meeting.
- Resolutions included director elections, auditor appointment, incentive-plan amendments, and article changes.
- Broader markets are weaker amid hotter producer-inflation concerns, but Noveris is moving opposite; trading activity and volume details were unavailable, leaving the reason uncertain.